These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17085901)

  • 1. [Janus-faced function of tumor suppressor genes as a new paradigm of cancer research--link between metabolic syndrome and carcinogenesis].
    Kawata S; Makino N
    Nihon Shokakibyo Gakkai Zasshi; 2006 Nov; 103(11):1215-22. PubMed ID: 17085901
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer biology. A matter of dosage.
    Fodde R; Smits R
    Science; 2002 Oct; 298(5594):761-3. PubMed ID: 12399571
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protein P53, protector of genome integrity: its role in carcinogenesis].
    Bellahcene A; Merville MP; Gielen J; Lambotte R; Simar L; Castronovo V
    Rev Med Liege; 1994 May; 49(5):274-84. PubMed ID: 8023054
    [No Abstract]   [Full Text] [Related]  

  • 4. [Genes and cancer. CHK2 (CDS1, Rad53): tumor suppressor gene].
    Uhrhammer N; Theillet C
    Bull Cancer; 2003 Jul; 90(7):581-2. PubMed ID: 12957797
    [No Abstract]   [Full Text] [Related]  

  • 5. At the crossroads: AMP-activated kinase and the LKB1 tumor suppressor link cell proliferation to metabolic regulation.
    Kyriakis JM
    J Biol; 2003; 2(4):26. PubMed ID: 14575531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atm heterozygosity does not increase tumor susceptibility to ionizing radiation alone or in a p53 heterozygous background.
    Mao JH; Wu D; DelRosario R; Castellanos A; Balmain A; Perez-Losada J
    Oncogene; 2008 Nov; 27(51):6596-600. PubMed ID: 18679420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Checkpoint gene linked to human cancer.
    Hagmann M
    Science; 1999 Dec; 286(5449):2433-4. PubMed ID: 10636795
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting the checkpoint kinases: chemosensitization versus chemoprotection.
    Zhou BB; Bartek J
    Nat Rev Cancer; 2004 Mar; 4(3):216-25. PubMed ID: 14993903
    [No Abstract]   [Full Text] [Related]  

  • 9. The regulation of CHK2 in human cancer.
    Craig AL; Hupp TR
    Oncogene; 2004 Nov; 23(52):8411-8. PubMed ID: 15361833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LKB1; linking cell structure and tumor suppression.
    Hezel AF; Bardeesy N
    Oncogene; 2008 Nov; 27(55):6908-19. PubMed ID: 19029933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers.
    Oliveira AM; Ross JS; Fletcher JA
    Am J Clin Pathol; 2005 Dec; 124 Suppl():S16-28. PubMed ID: 16468415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurora and the hunt for cancer-modifying genes.
    Dove W
    Nat Genet; 2003 Aug; 34(4):353-4. PubMed ID: 12923537
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor suppressor genes and breast cancer.
    Buchholz TA; Weil MM; Story MD; Strom EA; Brock WA; McNeese MD
    Radiat Oncol Investig; 1999; 7(2):55-65. PubMed ID: 10333246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenes and tumor suppressor genes.
    Carbone DP
    Hosp Pract (Off Ed); 1993 Jun; 28(6):145-8, 153-6, 161. PubMed ID: 8509476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heads and tails.Less-active tumor suppressor paradoxically promotes both longevity and cancer in humans.
    Beckman M
    Sci Aging Knowledge Environ; 2004 Nov; 2004(47):nf104. PubMed ID: 15564560
    [No Abstract]   [Full Text] [Related]  

  • 16. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth.
    Luo Z; Zang M; Guo W
    Future Oncol; 2010 Mar; 6(3):457-70. PubMed ID: 20222801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.
    Bell DW; Varley JM; Szydlo TE; Kang DH; Wahrer DC; Shannon KE; Lubratovich M; Verselis SJ; Isselbacher KJ; Fraumeni JF; Birch JM; Li FP; Garber JE; Haber DA
    Science; 1999 Dec; 286(5449):2528-31. PubMed ID: 10617473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular carcinogenesis of the uterine cervix].
    Enomoto T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():61-5. PubMed ID: 15535206
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of cancer suppressors, a driving force in carcinogenesis.
    Bouck NP; Benton BK
    Chem Res Toxicol; 1989; 2(1):1-11. PubMed ID: 2519224
    [No Abstract]   [Full Text] [Related]  

  • 20. p53, a translational regulator: contribution to its tumour-suppressor activity.
    Marcel V; Catez F; Diaz JJ
    Oncogene; 2015 Oct; 34(44):5513-23. PubMed ID: 25728674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.